Latham & Watkins represented Neumora in the deal. Amgen and Neumora Therapeutics, Inc., a clinical-stage biopharmaceutical company pioneering precision medicines for brain diseases, announced a strategic collaboration...
You must be a Standard 1 Year member to access this content.
Latham & Watkins advised Rivian Automotive, while Skadden, Arps, Slate, Meagher & Flom advised the underwriters in the Initial Public Offering. Rivian Automotive, Inc. has announced its...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented Agenus Inc. in the transaction. Agenus Inc. (Agenus), an immuno-oncology company with an extensive pipeline of checkpoint antibodies, cell therapies, adjuvants, and vaccines...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented Phononic in the transaction. Phononic, a global leader in sustainable solid-state cooling and heating technology, has secured a significant growth investment of...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Ginger on the deal, while Latham & Watkins represented Headspace. Ginger, a leading provider of on-demand mental healthcare, and Headspace, a...
You must be a Standard 1 Year member to access this content.
Latham & Watkins LLP represented Aligos Therapeutics, while Davis Polk advised the representatives of the several underwriters in the offering. Aligos Therapeutics, Inc. (Nasdaq: ALGS) announced...
You must be a Standard 1 Year member to access this content.
Latham & Watkins LLP represented GSK in the transaction. Alector, Inc. and GlaxoSmithKline plc, announced a strategic global collaboration for the development and commercialization of two...
You must be a Standard 1 Year member to access this content.
Latham & Watkins LLP represented GSK in the transaction. Alector, Inc. and GlaxoSmithKline plc, announced a strategic global collaboration for the development and commercialization of two...
You must be a Standard 1 Year member to access this content.
Goodwin Procter LLP advised Valo Health on the deal, while Latham & Watkins LLP represented Khosla Ventures Acquisition Co. Valo Health announced its definitive merger agreement with...
You must be a Standard 1 Year member to access this content.
Latham & Watkins LLP represented Frontier, while Davis Polk advised the representatives of the several underwriters in the offering. Frontier Group Holdings, Inc. (Frontier), a low-cost...
You must be a Standard 1 Year member to access this content.
Latham & Watkins LLP represented Senda Biosciences in the transaction. Senda Biosciences, a therapeutics platform company creating novel categories of medicines based on a new field...
You must be a Standard 1 Year member to access this content.
